Salona Global Medical Device Corporation
Símbolo: SGMD.V
TSX
0.22
CADPrecio de mercado actual
-15.8062
Ratio PER
0.2483
Ratio PEG
17.24M
Capitalización MRK
- 0.00%
Rendimiento DIV
Salona Global Medical Device Corporation (SGMD-V) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 8.1 | 7.6 | 9.2 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.net-receivables | 0 | 7 | 0.1 | 0.1 | |||||||||
balance-sheet.row.inventory | 0 | 5 | 0 | 0 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-current-assets | 0 | 20 | 13.1 | 9.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 5.4 | 0 | 0 | |||||||||
balance-sheet.row.goodwill | 0 | 9.8 | 0 | 0 | |||||||||
balance-sheet.row.intangible-assets | 0 | 6.9 | 0 | 0 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.8 | 0 | 0 | |||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.5 | 0 | 0 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 22.6 | 0 | 0 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.account-payables | 0 | 2.9 | 0.5 | 0.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 5.9 | 0 | 0 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 4.6 | 0 | 0 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 13.6 | 6 | 0 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.4 | 0 | 0 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 4.2 | 0 | 0 | |||||||||
balance-sheet.row.total-liab | 0 | 29.5 | 6.5 | 0.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 38.5 | 31.1 | 31.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -33.4 | -29 | -26.9 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1 | 0.9 | 1.4 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 7 | 3.6 | 3.4 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 42.7 | 13.1 | 9.3 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 13.2 | 6.6 | 9 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 0 | 0.5 | 0.8 | |||||||||
balance-sheet.row.total-debt | 0 | 10.5 | 0 | 0 | |||||||||
balance-sheet.row.net-debt | 0 | 2.5 | -7.1 | -8.3 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -4.4 | -2.7 | -1.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 1.2 | 0.2 | 0 | ||||||||
cash-flows.row.change-in-working-capital | 0 | -0.2 | 1.3 | 1.3 | ||||||||
cash-flows.row.account-receivables | 0 | -2.1 | -2.1 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | 0.2 | 0 | ||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-working-capital | 0 | 1.6 | 3.1 | 0 | ||||||||
cash-flows.row.other-non-cash-items | 0 | -1.1 | -0.5 | 0.3 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -5.1 | -5.1 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -0.4 | -0.9 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.4 | 0 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 5.1 | 0 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4.6 | 0.1 | -0.9 | ||||||||
cash-flows.row.debt-repayment | 0 | -2.5 | -2.5 | 0 | ||||||||
cash-flows.row.common-stock-issued | 0 | 4.3 | 4.3 | 0 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.other-financing-activites | 0 | 2.2 | 3.7 | 0 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 3.9 | 5.4 | 0 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -0.1 | -0.4 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -4.4 | 4.2 | -1 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 8.1 | 12.5 | 8.3 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 12.5 | 8.3 | 9.3 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -3.7 | -1 | -0.1 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.1 | -0.1 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -3.8 | -1 | -0.1 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 18.3 | 0 | 0.4 | ||||||||
income-statement-row.row.cost-of-revenue | 0 | 12.4 | 12.4 | 0.4 | ||||||||
income-statement-row.row.gross-profit | 0 | 6 | -12.4 | 0 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.operating-expenses | 0 | 6.6 | 1 | 1.7 | ||||||||
income-statement-row.row.cost-and-expenses | 0 | 18.9 | 1 | 2.1 | ||||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0 | -3.8 | -1.6 | 0 | ||||||||
income-statement-row.row.total-operating-expenses | 0 | -3.5 | -1.6 | 0 | ||||||||
income-statement-row.row.interest-expense | 0 | 0.4 | 0.4 | 0 | ||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0.8 | 0.8 | 0.1 | ||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||
income-statement-row.row.operating-income | 0 | -4.5 | -1 | -1.7 | ||||||||
income-statement-row.row.income-before-tax | 0 | -4.5 | -2.7 | -1.8 | ||||||||
income-statement-row.row.income-tax-expense | 0 | -0.1 | -0.1 | 0.6 | ||||||||
income-statement-row.row.net-income | 0 | -4.4 | -2.7 | -2.3 |
Preguntas frecuentes
Cuánto es Salona Global Medical Device Corporation (SGMD.V) activos totales?
Salona Global Medical Device Corporation (SGMD.V) los activos totales son 42681612.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son N/A.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.357.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -0.015.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.023.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son -0.080.
¿Qué es Salona Global Medical Device Corporation (SGMD.V) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -4372019.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 10533056.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 6570013.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 0.000.